Answers are grounded in this paper and cite their sources.
The 5-lipoxygenase pathway is highlighted as a potential pathophysiological factor and future therapeutic target in degenerative aortic stenosis.
Evaluation of: Nagy E, Andersson DC, Caidahl K et al. Upregulation of the 5-lipoxygenase pathway in human aortic valves correlates with severity of stenosis and leads to leukotriene-induced effects on valvular myofibroblasts. Circulation DOI: 10.1161/CIRCULATIONAHA.110.966846 (2011) (Epub ahead of print).Understanding the exact pathophysiological mechanism of degenerative aortic stenosis is important in order to develop new treatment modalities and prevent progression of the disease. Recently, most of the inflammatory markers in association with aortic stenosis have been described. The authors of the paper under evaluation investigate the effects of the 5-lipoxygenase pathway on aortic valve stenosis and correlation with severity of stenosis. In this article, we suggest that the 5-lipoxygenase pathway is one of the possible factors in the development of aortic stenosis.
No takes yet. Share an insight, caveat, or question.
Akdemir et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: